{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:40:56Z","timestamp":1791895256050,"version":"4.3.4"},"reference-count":240,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007743","name":"ESPEN","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.clnu.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T08:13:21Z","timestamp":1458029601000},"page":"557-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":457,"title":["ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Dominique","family":"Turck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Braegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0857-874X","authenticated-orcid":false,"given":"Dimitri","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzha","family":"Pancheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8165-4465","authenticated-orcid":false,"given":"Eddy","family":"Robberecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Strandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6256-8169","authenticated-orcid":false,"given":"Stephane M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilschanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2016.03.004_bib1","first-page":"CD006751","article-title":"Vitamin A supplementation for cystic fibrosis","volume":"5","author":"Bonifant","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib2","first-page":"CD008190","article-title":"Appetite stimulants for people with cystic fibrosis","volume":"7","author":"Chinuck","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib3","first-page":"CD007020","article-title":"Antioxidant supplementation for lung disease in cystic fibrosis","volume":"8","author":"Ciofu","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib4","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis","volume":"3","author":"Conwell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib5","first-page":"CD007298","article-title":"Vitamin D supplementation for cystic fibrosis","volume":"5","author":"Ferguson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib6","first-page":"CD009422","article-title":"Vitamin E supplementation in people with cystic fibrosis","volume":"12","author":"Okebukola","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib7","first-page":"CD000406","article-title":"Oral calorie supplements for cystic fibrosis","volume":"11","author":"Smyth","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib8","first-page":"CD008227","article-title":"Pancreatic enzyme replacement therapy for people with cystic fibrosis","volume":"10","author":"Somaraju","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005176-200209000-00004","article-title":"Consensus report on nutrition for pediatric patients with cystic fibrosis","volume":"35","author":"Borowitz","year":"2002","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib10","series-title":"Nutritional management of cystic fibrosis","author":"Cystic Fibrosis Trust","year":"2002"},{"key":"10.1016\/j.clnu.2016.03.004_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis: a European Consensus","volume":"1","author":"Sinaasappel","year":"2002","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clnu.2011.07.006","article-title":"ESPEN disease-specific guideline framework","volume":"30","author":"Preiser","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib13","series-title":"Clinical guidelines: criteria for appraisal for national use","author":"Petrie","year":"1995"},{"key":"10.1016\/j.clnu.2016.03.004_bib14","series-title":"Acute pain management, operative or medical procedures and trauma Rockville, MD, USA","author":"Agency for Health Care Policy and Research","year":"1992"},{"key":"10.1016\/j.clnu.2016.03.004_bib15","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.clnu.2016.03.004_bib16","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7","author":"Edenborough","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcf.2011.10.007","article-title":"A\u00a0fat lot of good: balance and trends in fat intake in children with cystic fibrosis","volume":"11","author":"Smith","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1177\/0884533613507086","article-title":"Malnutrition in cystic fibrosis: a review","volume":"28","author":"Culhane","year":"2013","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2016.03.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3476(05)83478-X","article-title":"The changing epidemiology of cystic fibrosis","volume":"122","author":"FitzSimmons","year":"1993","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2006.05.008","article-title":"A\u00a0survey of newborn screening for cystic fibrosis in Europe","volume":"6","author":"Southern","year":"2007","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201009-1478CI","article-title":"Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life","volume":"183","author":"Cohen-Cymberknoh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.dld.2014.06.011","article-title":"Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy","volume":"46","author":"Li","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnu.2016.03.004_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MCO.0000000000000100","article-title":"Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis","volume":"17","author":"Engelen","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2016.03.004_bib25","first-page":"151","article-title":"Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies","volume":"6","author":"Kalnins","year":"2012","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clnu.2016.03.004_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2010.07.002","article-title":"Fatty acid metabolism in cystic fibrosis","volume":"83","author":"Strandvik","year":"2010","journal-title":"Prostagl Leukot Essent Fat Acids"},{"key":"10.1016\/j.clnu.2016.03.004_bib27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ejcn.2013.20","article-title":"Nutritional care in children with cystic fibrosis: are our patients becoming better?","volume":"67","author":"Gaskin","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A\u00a0comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clnu.2016.03.004_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2016.03.004_bib30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(09)62161-9","article-title":"Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis","volume":"375","author":"McCormick","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2016.03.004_bib31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MPG.0b013e3182618f33","article-title":"Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis","volume":"55","author":"Maqbool","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.clnu.2016.03.004_bib32","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jcf.2014.03.010","article-title":"European cystic fibrosis Society standards of care: best practice guidelines","volume":"13","author":"Smyth","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib33","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study","volume":"97","author":"Stephenson","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib34","series-title":"ECFSPR annual report 2010","author":"Zolin","year":"2014"},{"key":"10.1016\/j.clnu.2016.03.004_bib35","series-title":"2011 annual data report","author":"Cystic Fibrosis Foundation Patient Registry","year":"2011"},{"key":"10.1016\/j.clnu.2016.03.004_bib36","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jdiacomp.2014.06.012","article-title":"Cystic fibrosis related diabetes-a new perspective on the optimal management of postprandial glycemia","volume":"28","author":"Perano","year":"2014","journal-title":"J\u00a0Diabetes Complicat"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.clnu.2016.03.004_bib37","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bpg.2005.11.006","article-title":"Cystic fibrosis: nutritional consequences and management","volume":"20","author":"Dodge","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clnu.2016.03.004_bib39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3476(87)80107-5","article-title":"Energy expenditure of patients with cystic fibrosis","volume":"111","author":"Vaisman","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1054\/clnu.2001.0522","article-title":"Resting energy expenditure in young patients with cystic fibrosis receiving antibiotic therapy for acute respiratory exacerbations","volume":"21","author":"Castro","year":"2002","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.clnu.2004.06.010","article-title":"Energy balance in cystic fibrosis when stable and during a respiratory exacerbation","volume":"23","author":"Mc Closkey","year":"2004","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-981651","article-title":"How can we prevent multisystem complications of cystic fibrosis?","volume":"28","author":"Elborn","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1017\/S0029665109990176","article-title":"Symposium 6: young people, artificial nutrition and transitional care. The nutritional challenges of the young adult with cystic fibrosis: transition","volume":"68","author":"Morton","year":"2009","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.clnu.2016.03.004_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","article-title":"Treatment of lung infection in patients with cystic fibrosis: current and future strategies","volume":"11","author":"Doring","year":"2012","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005176-199107000-00010","article-title":"Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis","volume":"13","author":"Greer","year":"1991","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib46","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1067\/mpd.2003.152","article-title":"Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis","volume":"142","author":"Konstan","year":"2003","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib47","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1542\/peds.113.6.1549","article-title":"Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition","volume":"113","author":"Koscik","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2016.03.004_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.clnu.2012.08.017","article-title":"Stunting is an independent predictor of mortality in patients with cystic fibrosis","volume":"32","author":"Vieni","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jcf.2013.01.006","article-title":"Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9\u201319 years","volume":"12","author":"Shoff","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jcf.2014.07.010","article-title":"Cystic fibrosis mortality trend in Italy from 1970 to 2011","volume":"14","author":"Alicandro","year":"2015","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clnu.2011.09.007","article-title":"Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance","volume":"31","author":"Alicandro","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib52","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/BF01957574","article-title":"Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis","volume":"151","author":"Lanng","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib53","doi-asserted-by":"crossref","DOI":"10.3310\/hta16240","article-title":"Screening for cystic fibrosis-related diabetes: a systematic review","volume":"16","author":"Waugh","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clnu.2016.03.004_bib54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2016.03.004_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-7075-2-11","article-title":"Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency","volume":"2","author":"Peretti","year":"2005","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.clnu.2016.03.004_bib56","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/thorax.55.9.798","article-title":"Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors","volume":"55","author":"Conway","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.clnu.2016.03.004_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jbspin.2011.05.009","article-title":"Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers","volume":"79","author":"Legroux-Gerot","year":"2012","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.clnu.2016.03.004_bib58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jbspin.2010.11.015","article-title":"Bone disease in cystic fibrosis: what's new?","volume":"78","author":"Javier","year":"2011","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.clnu.2016.03.004_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.105.1.53","article-title":"Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening","volume":"105","author":"Lai","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2016.03.004_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2012.08.040","article-title":"Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis","volume":"162","author":"Yen","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib61","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1651-2227.1997.tb14836.x","article-title":"Failure to thrive: the earliest feature of cystic fibrosis in infants diagnosed by neonatal screening","volume":"86","author":"Giglio","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib62","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcf.2010.04.008","article-title":"Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening","volume":"9","author":"Sermet-Gaudelus","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib64","series-title":"The WHO child growth standards","year":"2006"},{"key":"10.1016\/j.clnu.2016.03.004_bib65","series-title":"Standards for the clinical care of children and adults with cystic fibrosis in the UK","author":"Cystic Fibrosis Trust","year":"2011"},{"key":"10.1016\/j.clnu.2016.03.004_bib66","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/0884533610374198","article-title":"Update in pediatrics: focus on fat-soluble vitamins","volume":"25","author":"Sathe","year":"2010","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2016.03.004_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cccn.2004.11.002","article-title":"Circulating markers to assess nutritional therapy in cystic fibrosis","volume":"353","author":"Wood","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clnu.2016.03.004_bib68","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jcf.2013.11.001","article-title":"Recurrent pulmonary exacerbations are associated with low fat free mass and low bone mineral density in young adults with cystic fibrosis","volume":"13","author":"Alicandro","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1164\/ajrccm.165.4.2104065","article-title":"Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis","volume":"165","author":"Ionescu","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib70","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis","volume":"90","author":"Aris","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.clnu.2016.03.004_bib71","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/S1569-1993(11)60004-0","article-title":"European cystic fibrosis bone mineralisation guidelines","volume":"10","author":"Sermet-Gaudelus","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib72","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1056\/NEJM197304192881603","article-title":"Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency","volume":"288","author":"DiMagno","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib73","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/jgh.12785","article-title":"Cystic fibrosis: an update for clinicians. Part 2: Hepatobiliary and pancreatic manifestations","volume":"29","author":"Ledder","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2016.03.004_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2010.10.005","article-title":"Pregnancy in cystic fibrosis","volume":"32","author":"McArdle","year":"2011","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib75","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jpeds.2009.09.002","article-title":"Management of infants with cystic fibrosis: a summary of the evidence for the cystic fibrosis foundation working group on care of infants with cystic fibrosis","volume":"155","author":"Robinson","year":"2009","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib76","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1651-2227.2007.00397.x","article-title":"Benefits of breastfeeding in cystic fibrosis: a single-centre follow-up survey","volume":"96","author":"Colombo","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcf.2004.12.002","article-title":"Standards of care for patients with cystic fibrosis: a European consensus","volume":"4","author":"Kerem","year":"2005","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib78","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jcf.2010.07.002","article-title":"Mealtime interactions in families of a child with cystic fibrosis: a meta-analysis","volume":"9","author":"Hammons","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib79","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00004703-199406000-00001","article-title":"Behavior at mealtimes and the young child with cystic fibrosis","volume":"15","author":"Crist","year":"1994","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00005176-200304000-00004","article-title":"Feeding behavior problems in children with cystic fibrosis in the UK: prevalence and comparison with healthy controls","volume":"36","author":"Duff","year":"2003","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3476(00)70101-6","article-title":"Parent and child mealtime behavior in families of children with cystic fibrosis","volume":"136","author":"Stark","year":"2000","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib82","article-title":"EFSA Panel on Dietetic Products Nutrition and Allergies. Scientific opinion on dietary reference values for energy","volume":"11","year":"2013","journal-title":"EFSA J"},{"key":"10.1016\/j.clnu.2016.03.004_bib83","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.1177\/0148607111420156","article-title":"Nutritional management of cystic fibrosis","volume":"36","author":"Matel","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib84","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.clnu.2013.07.011","article-title":"Dietary intake in children and adolescents with cystic fibrosis","volume":"33","author":"Woestenenk","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib85","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-3476(73)80139-8","article-title":"Metabolic alkalosis and salt depletion in cystic fibrosis","volume":"82","author":"Arvanitakis","year":"1973","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib86","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcf.2009.08.006","article-title":"Evaluation of salt supplementation in CF infants","volume":"8","author":"Coates","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib87","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01972892","article-title":"Sodium chloride deficiency in cystic fibrosis patients","volume":"153","author":"Ozcelik","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib88","article-title":"Commission Directive 2006\/141\/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999\/21\/EC Text with EEA relevance","year":"2006","journal-title":"Off J Eur Union"},{"key":"10.1016\/j.clnu.2016.03.004_bib89","series-title":"Krause's food and the nutrition care process","first-page":"782","article-title":"Medical nutrition therapy for pulmonoary disease","author":"Meuller","year":"2012"},{"key":"10.1016\/j.clnu.2016.03.004_bib90","series-title":"Bone Mineralisation Working Group, Bone mineralisation in cystic fibrosis","author":"Cystic Fibrosis Trust","year":"2007"},{"key":"10.1016\/j.clnu.2016.03.004_bib91","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1067\/S0022-3476(03)00539-0","article-title":"Endogenous fecal losses of calcium compromise calcium balance in pancreatic-insufficient girls with cystic fibrosis","volume":"143","author":"Schulze","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.clnu.2016.03.004_bib92","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.2903\/j.efsa.2015.4101","article-title":"Scientific opinion on dietary reference values for calcium","volume":"13","author":"EFSA NDA Panel (EFSA Panel on Dietetic Products Nutrition and Allergies)","year":"2015","journal-title":"EFSA J"},{"key":"10.1016\/j.clnu.2016.03.004_bib93","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/ajcn\/82.5.1115","article-title":"Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial","volume":"82","author":"Cheng","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib94","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ppul.22857","article-title":"Iron deficiency occurs frequently in children with cystic fibrosis","volume":"49","author":"Uijterschout","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib95","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ppul.21335","article-title":"Iron and CF-related anemia: expanding clinical and biochemical relationships","volume":"46","author":"Gifford","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib96","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/0884533608323426","article-title":"Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency","volume":"23","author":"von Drygalski","year":"2008","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2016.03.004_bib97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0884533614527773","article-title":"Pancreatic enzyme replacement therapy during pancreatic insufficiency","volume":"29","author":"Berry","year":"2014","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2016.03.004_bib98","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcf.2014.03.007","article-title":"The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis","volume":"13","author":"Uijterschout","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib99","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/ppul.20717","article-title":"Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis","volume":"42","author":"Fischer","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib100","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib101","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ppul.10195","article-title":"Plasma and red blood cell zinc in cystic fibrosis","volume":"35","author":"Akanli","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.mpg.0000228093.36089.35","article-title":"Plasma zinc and growth status in preadolescent children with cystic fibrosis","volume":"43","author":"Maqbool","year":"2006","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib103","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1651-2227.1983.tb09743.x","article-title":"Plasma and erythrocyte zinc, copper and selenium in cystic fibrosis","volume":"72","author":"Neve","year":"1983","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.clnu.2016.03.004_bib104","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/157339609789007222","article-title":"Importance of zinc in cystic fibrosis patients","volume":"5","author":"Van Biervliet","year":"2009","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.201303-0427OC","article-title":"Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial","volume":"188","author":"Griese","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib106","first-page":"CD007020","article-title":"Antioxidant micronutrients for lung disease in cystic fibrosis","author":"Shamseer","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0891-5849(98)00061-6","article-title":"Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in cystic fibrosis","volume":"25","author":"Winklhofer-Roob","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib108","series-title":"Krause's food and the nutrition care process","first-page":"32","article-title":"Intake: the nutrients and their metabolism","author":"Gallagher","year":"2012"},{"key":"10.1016\/j.clnu.2016.03.004_bib109","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00394-002-0369-z","article-title":"Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway","volume":"41","author":"Dorlochter","year":"2002","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jclinpath-2013-201787","article-title":"Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis","volume":"67","author":"Rana","year":"2014","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.clnu.2016.03.004_bib111","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCP.0b013e3283136787","article-title":"Update on fat-soluble vitamins in cystic fibrosis","volume":"14","author":"Maqbool","year":"2008","journal-title":"Curr Opin Pulm Med"},{"issue":"Suppl.\u00a027","key":"10.1016\/j.clnu.2016.03.004_bib112","first-page":"3","article-title":"Annual review or continuous assessment?","volume":"89","author":"Carr","year":"1996","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib113","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3476(99)70059-4","article-title":"Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen","volume":"135","author":"Feranchak","year":"1999","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib114","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.clnu.2013.01.009","article-title":"Individualized vitamin A supplementation for patients with cystic fibrosis","volume":"32","author":"Brei","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02002713","article-title":"Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation","volume":"155","author":"Lancellotti","year":"1996","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib116","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPG.0b013e31804069e5","article-title":"Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis","volume":"45","author":"Hakim","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib117","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcf.2006.08.001","article-title":"Facial nerve palsy associated with a low serum vitamin A level in an infant with cystic fibrosis","volume":"6","author":"Cameron","year":"2007","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib118","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.83.6.688","article-title":"Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements","volume":"83","author":"Ansari","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clnu.2016.03.004_bib119","series-title":"Tolerable upper intake levels for vitamins and minerals","author":"Scientific Committee on Food","year":"2006"},{"key":"10.1016\/j.clnu.2016.03.004_bib120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00005176-199703000-00006","article-title":"Vitamin A concentration in the liver decreases with age in patients with cystic fibrosis","volume":"24","author":"Lindblad","year":"1997","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib121","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jcf.2007.07.002","article-title":"Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis","volume":"7","author":"Maqbool","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib122","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000012818","article-title":"Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function","volume":"44","author":"Rust","year":"2000","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.clnu.2016.03.004_bib123","series-title":"Basics in clinical nutrition","first-page":"145","article-title":"Physiological function and deficiency states of vitamins","author":"Shenkin","year":"2011"},{"key":"10.1016\/j.clnu.2016.03.004_bib124","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/ajcn\/84.1.174","article-title":"Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis","volume":"84","author":"Graham-Maar","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib125","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/ajcn\/78.6.1152","article-title":"Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations","volume":"78","author":"Myhre","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib126","series-title":"Dietary reference intakes: vitamin A, K, iron, zinc, and other elements","first-page":"773","author":"IOM (Institute of Medicine)","year":"2001"},{"key":"10.1016\/j.clnu.2016.03.004_bib127","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00431-006-0120-5","article-title":"Maternal vitamin A deficiency and neonatal microphthalmia: complications of biliopancreatic diversion?","volume":"165","author":"Smets","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib128","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jpeds.2008.04.058","article-title":"Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate","volume":"153","author":"Green","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib129","doi-asserted-by":"crossref","first-page":"218691","DOI":"10.1155\/2010\/218691","article-title":"Vitamin d deficiency in cystic fibrosis","volume":"2010","author":"Hall","year":"2010","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.clnu.2016.03.004_bib130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ejcn.2010.280","article-title":"Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis","volume":"65","author":"Robberecht","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib131","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2016.03.004_bib132","article-title":"EFSA panel on dietetic products nutrition and allergies. Scientific opinion on the tolerable upper intake level of vitamin D","volume":"10","year":"2012","journal-title":"EFSA J"},{"key":"10.1016\/j.clnu.2016.03.004_bib133","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/MPG.0b013e31828f3c05","article-title":"Vitamin D in the healthy European paediatric population","volume":"56","author":"Braegger","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib134","series-title":"Dietary reference intakes for calcium and vitamin D","author":"IOM (Institute of Medicine)","year":"2011"},{"key":"10.1016\/j.clnu.2016.03.004_bib135","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3945\/ajcn.111.031070","article-title":"Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis","volume":"95","author":"Tripkovic","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib136","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcf.2012.08.007","article-title":"Single high-dose oral vitamin D(3) (stoss) therapy \u2013 a solution to vitamin D deficiency in children with cystic fibrosis?","volume":"12","author":"Shepherd","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib137","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2012.00471.x","article-title":"Vitamin D bioavailability in cystic fibrosis: a cause for concern?","volume":"70","author":"Mailhot","year":"2012","journal-title":"Nutr Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ppul.20041","article-title":"Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation","volume":"38","author":"Lagrange-Puget","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib139","doi-asserted-by":"crossref","first-page":"C262","DOI":"10.1152\/ajpcell.00070.2005","article-title":"Oxidant stress suppresses CFTR expression","volume":"290","author":"Cantin","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.clnu.2016.03.004_bib140","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2005.11.016","article-title":"Vitamin E status in children with cystic fibrosis and pancreatic insufficiency","volume":"148","author":"Huang","year":"2006","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib141","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ajcn\/63.5.722","article-title":"Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations","volume":"63","author":"Winklhofer-Roob","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib142","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcf.2009.09.002","article-title":"Prevalence of dyslipidemia in adults with cystic fibrosis","volume":"9","author":"Rhodes","year":"2010","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib143","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1745-7599.2012.00763.x","article-title":"Cystic fibrosis: a clinician's tool for management of care advancing into the adult population","volume":"24","author":"Nast","year":"2012","journal-title":"J\u00a0Am Acad Nurse Pract"},{"key":"10.1016\/j.clnu.2016.03.004_bib144","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3945\/ajcn.2010.29350","article-title":"Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis","volume":"92","author":"Dougherty","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcn\/70.3.378","article-title":"Prevalence of vitamin K deficiency in cystic fibrosis","volume":"70","author":"Rashid","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib146","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1542\/peds.2004-1242","article-title":"Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover","volume":"115","author":"Conway","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2016.03.004_bib147","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jcf.2008.04.001","article-title":"Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis","volume":"7","author":"Drury","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib148","first-page":"CD008482","article-title":"Vitamin K supplementation for cystic fibrosis","author":"Jagannath","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib149","first-page":"47","article-title":"Coefficients of fat and nitrogen absorption in healthy subjects and individuals with cystic fibrosis","volume":"12","author":"Borowitz","year":"2007","journal-title":"J\u00a0Pediatr Pharmacol Ther"},{"key":"10.1016\/j.clnu.2016.03.004_bib150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1345\/aph.1P770","article-title":"Pancreatic enzyme products: digesting the changes","volume":"45","author":"Giuliano","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clnu.2016.03.004_bib151","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2009.08.008","article-title":"Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis","volume":"8","author":"Trapnell","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib152","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MOP.0b013e32834a1b33","article-title":"Pancreatic enzyme supplementation","volume":"23","author":"Wier","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib153","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcf.2009.07.006","article-title":"EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency","volume":"8","author":"Wooldridge","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2014.01.022","article-title":"Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis","volume":"164","author":"Haupt","year":"2014","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11894-007-0005-4","article-title":"Pancreatic enzyme therapy for pancreatic exocrine insufficiency","volume":"9","author":"Dominguez-Munoz","year":"2007","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clnu.2016.03.004_bib156","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jada.2006.05.011","article-title":"An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study","volume":"106","author":"Brady","year":"2006","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2016.03.004_bib157","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MPA.0b013e3181a85eaf","article-title":"Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study","volume":"38","author":"Colombo","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.clnu.2016.03.004_bib158","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcf.2014.07.006","article-title":"Safety and efficacy of Creon(R) Micro in children with exocrine pancreatic insufficiency due to cystic fibrosis","volume":"14","author":"Kashirskaya","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib159","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jcf.2008.07.003","article-title":"Pancreatic enzyme replacement therapy for young cystic fibrosis patients","volume":"8","author":"Munck","year":"2009","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinthera.2010.01.012","volume":"32","author":"Graff","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.clnu.2016.03.004_bib161","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/11533390-000000000-00000","article-title":"Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study","volume":"30","author":"Graff","year":"2010","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clnu.2016.03.004_bib162","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPG.0b013e31817fb76b","article-title":"Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis","volume":"47","author":"Maqbool","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib163","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/00005176-200010000-00016","article-title":"Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients","volume":"31","author":"Steinkamp","year":"2000","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib164","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ajcn\/63.5.746","article-title":"Effect of linoleic acid intake on growth of infants with cystic fibrosis","volume":"63","author":"van Egmond","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib165","first-page":"CD001198","article-title":"Enteral tube feeding for cystic fibrosis","volume":"12","author":"Conway","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib166","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/adc.2005.080333","article-title":"Failure to thrive: the prevalence and concurrence of anthropometric criteria in a general infant population","volume":"92","author":"Olsen","year":"2007","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clnu.2016.03.004_bib167","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ajcn\/88.1.161","article-title":"Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance","volume":"88","author":"Lai","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib168","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/00365528809090239","article-title":"Food intake in patients with cystic fibrosis on an ordinary diet","volume":"143","author":"Kindstedt-Arfwidson","year":"1988","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.clnu.2016.03.004_bib169","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s004310050750","article-title":"Essential fatty acid deficiency in well nourished young cystic fibrosis patients","volume":"156","author":"Roulet","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib170","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0022-3476(98)70025-3","article-title":"Nutrition intervention for weight gain in cystic fibrosis: a meta analysis","volume":"132","author":"Jelalian","year":"1998","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib171","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jcf.2005.05.015","article-title":"Mealtime behaviors in families of infants and toddlers with cystic fibrosis","volume":"4","author":"Powers","year":"2005","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib172","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archpediatrics.2009.165","article-title":"Randomized clinical trial of behavioral intervention and nutrition education to improve caloric intake and weight in children with cystic fibrosis","volume":"163","author":"Stark","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib173","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ppul.21322","article-title":"The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF","volume":"46","author":"Stark","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib174","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clnu.2006.08.002","article-title":"Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis","volume":"26","author":"Abbott","year":"2007","journal-title":"Clin Nutr"},{"issue":"Suppl.\u00a044","key":"10.1016\/j.clnu.2016.03.004_bib175","first-page":"36","article-title":"The nature and prevalence of eating disorders and eating disturbance in adolescents with cystic fibrosis","volume":"97","author":"Shearer","year":"2004","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib176","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/01.MPG.0000154656.64073.E1","article-title":"Attitudes toward percutaneous endoscopic gastrostomy placement in cystic fibrosis patients","volume":"40","author":"Gunnell","year":"2005","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib177","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-8223(95)00121-2","article-title":"Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis","volume":"95","author":"Rettammel","year":"1995","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnu.2016.03.004_bib178","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ajcn\/48.2.235","article-title":"Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects of protein turnover","volume":"48","author":"Shepherd","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib179","first-page":"42","article-title":"Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture","volume":"25","author":"Caramia","year":"2003","journal-title":"Pediatr Med Chir"},{"key":"10.1016\/j.clnu.2016.03.004_bib180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.arbres.2009.11.001","article-title":"Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis","volume":"46","author":"Olveira","year":"2010","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.clnu.2016.03.004_bib181","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MPG.0b013e3182250c43","article-title":"A\u00a0pre-post retrospective study of patients with cystic fibrosis and gastrostomy tubes","volume":"53","author":"Best","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib182","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3945\/ajcn.112.043406","article-title":"Genetic modifiers of nutritional status in cystic fibrosis","volume":"96","author":"Bradley","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib183","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.mpg.0000189348.09925.02","article-title":"Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease","volume":"42","author":"Efrati","year":"2006","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib184","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3476(94)70312-4","article-title":"Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis","volume":"124","author":"Steinkamp","year":"1994","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1874306400903010112","article-title":"The long term efficacy of gastrostomy feeding in children with cystic fibrosis on anthropometric markers of nutritonal status and pulmonary function","volume":"3","author":"Truby","year":"2009","journal-title":"Open Respir Med J"},{"key":"10.1016\/j.clnu.2016.03.004_bib186","first-page":"241","article-title":"Percutaneous endoscopic gastrostomy in cystic fibrosis: patient acceptance and effect of overnight tube feeding on nutritional status","volume":"67","author":"Van Biervliet","year":"2004","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.clnu.2016.03.004_bib187","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005176-199807000-00009","article-title":"Pulmonary function correlates in the prediction of long-term weight gain in cystic fibrosis patients with gastrostomy tube feedings","volume":"27","author":"Walker","year":"1998","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib188","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.clnu.2016.03.004_bib189","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib190","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MCP.0b013e32833e2e94","article-title":"Impact of cystic fibrosis on bone health","volume":"16","author":"Haworth","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib191","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/thx.2005.046516","article-title":"Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis","volume":"61","author":"Buntain","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.clnu.2016.03.004_bib192","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2431-9-61","article-title":"Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study","volume":"9","author":"Lucidi","year":"2009","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib193","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1651-2227.2003.tb00495.x","article-title":"Association between serum oncofetal antigens CA 19-9 and CA 125 and clinical status in patients with cystic fibrosis","volume":"92","author":"Gronowitz","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib194","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1017\/S000711450780105X","article-title":"Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis","volume":"99","author":"Gronowitz","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib195","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1079\/BJN20061778","article-title":"Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis","volume":"95","author":"Gronowitz","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib196","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcf.2008.04.004","article-title":"A\u00a0cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre","volume":"7","author":"Conway","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib197","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1651-2227.2003.tb00601.x","article-title":"Decreased bone mineral density in normal-growing patients with cystic fibrosis","volume":"92","author":"Gronowitz","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib198","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jcf.2007.11.006","article-title":"Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis","volume":"7","author":"Fewtrell","year":"2008","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib199","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl.\u00a020","key":"10.1016\/j.clnu.2016.03.004_bib200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/pedi.12178","article-title":"Management of cystic fibrosis-related diabetes in children and adolescents","volume":"15","author":"Moran","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.clnu.2016.03.004_bib201","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2016.03.004_bib202","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2016.03.004_bib203","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1515\/CCLM.2010.336","article-title":"Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease","volume":"48","author":"Van Biervliet","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib204","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1432-2277.2004.00013.x","article-title":"Effects of liver transplantation on the nutritional status of patients with cystic fibrosis","volume":"18","author":"Colombo","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.clnu.2016.03.004_bib205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0952-3278(96)90087-3","article-title":"Current knowledge on fatty acids in cystic fibrosis","volume":"55","author":"Christophe","year":"1996","journal-title":"Prostagl Leukot Essent Fat Acids"},{"key":"10.1016\/j.clnu.2016.03.004_bib206","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa021218","article-title":"Association of cystic fibrosis with abnormalities in fatty acid metabolism","volume":"350","author":"Freedman","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib207","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1067\/mpd.2001.118890","article-title":"Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis","volume":"139","author":"Strandvik","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib208","doi-asserted-by":"crossref","first-page":"9202","DOI":"10.1073\/pnas.83.23.9202","article-title":"Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect","volume":"83","author":"Carlstedt-Duke","year":"1986","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.clnu.2016.03.004_bib209","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-3476(62)80065-1","article-title":"The fatty acid composition of the serum chylomicrons and adipose tissue of children with cystic fibrosis of the pancreas","volume":"60","author":"Kuo","year":"1962","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinbiochem.2007.01.002","article-title":"An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis","volume":"40","author":"Coste","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clnu.2016.03.004_bib211","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/MPG.0b013e318249438c","article-title":"Long-chain PUFA in granulocytes, mononuclear cells, and RBC in patients with cystic fibrosis: relation to liver disease","volume":"55","author":"Jorgensen","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbalip.2011.05.002","article-title":"Increased Delta5- and Delta6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis","volume":"1811","author":"Njoroge","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clnu.2016.03.004_bib213","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcf.2011.03.008","article-title":"Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice","volume":"10","author":"Wouthuyzen-Bakker","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2016.03.004_bib214","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1651-2227.1996.tb13947.x","article-title":"Essential fatty acid deficiency and predisposition to lung disease in cystic fibrosis","volume":"85","author":"Lloyd-Still","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib215","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MPG.0b013e3180690da9","article-title":"Polyunsaturated fatty acids in cystic fibrosis are related to nutrition and clinical expression of the disease","volume":"45","author":"Walkowiak","year":"2007","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib216","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clnu.2005.10.011","article-title":"Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial","volume":"25","author":"Panchaud","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib217","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(89)80072-1","article-title":"Effect on renal function of essential fatty acid supplementation in cystic fibrosis","volume":"115","author":"Strandvik","year":"1989","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib218","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.plefa.2012.10.002","article-title":"A\u00a0randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis","volume":"88","author":"Alicandro","year":"2013","journal-title":"Prostagl Leukot Essent Fat Acids"},{"key":"10.1016\/j.clnu.2016.03.004_bib219","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/014860710302700152","article-title":"Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis","volume":"27","author":"De Vizia","year":"2003","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib220","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/MPG.0b013e3181b47967","article-title":"Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis","volume":"50","author":"Keen","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib221","first-page":"CD002201","article-title":"Omega-3 fatty acids for cystic fibrosis","volume":"11","author":"Oliver","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib222","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-2600(13)70064-X","article-title":"Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate","volume":"1","author":"Bianchi","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.clnu.2016.03.004_bib223","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/01.med.0000436191.87727.ec","article-title":"Cystic fibrosis-related bone disease: insights into a growing problem","volume":"20","author":"Stalvey","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.clnu.2016.03.004_bib224","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1359\/jbmr.080511","article-title":"Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases","volume":"23","author":"Whyte","year":"2008","journal-title":"J\u00a0Bone Min Res"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.clnu.2016.03.004_bib225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000110603","article-title":"A\u00a0review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth","volume":"68","author":"Hardin","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/j.clnu.2016.03.004_bib226","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1359\/JBMR.051106","article-title":"BMD and body composition in children and young patients affected by cystic fibrosis","volume":"21","author":"Bianchi","year":"2006","journal-title":"J\u00a0Bone Min Res"},{"key":"10.1016\/j.clnu.2016.03.004_bib227","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1542\/peds.2010-2007","article-title":"Recombinant human growth hormone in the treatment of patients with cystic fibrosis","volume":"126","author":"Phung","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.clnu.2016.03.004_bib228","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ppul.21546","article-title":"A\u00a0multi-center controlled trial of growth hormone treatment in children with cystic fibrosis","volume":"47","author":"Stalvey","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib229","first-page":"CD008901","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","volume":"6","author":"Thaker","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnu.2016.03.004_bib230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00005176-200009000-00012","article-title":"Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis","volume":"31","author":"Marchand","year":"2000","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib231","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1067\/mpd.2002.121936","article-title":"Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis","volume":"140","author":"Eubanks","year":"2002","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnu.2016.03.004_bib232","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ppul.20043","article-title":"Cyproheptadine is an effective appetite stimulant in cystic fibrosis","volume":"38","author":"Homnick","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib233","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2223\/JPED.2174","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis","volume":"88","author":"Epifanio","year":"2012","journal-title":"J\u00a0Pediatr (Rio J)"},{"key":"10.1016\/j.clnu.2016.03.004_bib234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.medmal.2013.10.002","article-title":"Probiotics, gut microbiota and health","volume":"44","author":"Butel","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.clnu.2016.03.004_bib235","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1039\/c3fo60600g","article-title":"Probiotic actions on diseases: implications for therapeutic treatments","volume":"5","author":"Chiu","year":"2014","journal-title":"Food Funct"},{"key":"10.1016\/j.clnu.2016.03.004_bib236","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2004.02174.x","article-title":"Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration","volume":"20","author":"Bruzzese","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2016.03.004_bib237","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clnu.2007.01.004","article-title":"Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study","volume":"26","author":"Bruzzese","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2016.03.004_bib238","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ppul.21138","article-title":"Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study","volume":"45","author":"Weiss","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.clnu.2016.03.004_bib239","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Kerem","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.clnu.2016.03.004_bib240","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561416000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561416000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T04:12:56Z","timestamp":1655266376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561416000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":240,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0261561416000959"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2016.03.004","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}